| Laura K Weinbrenner, CCC-SLP/L | |
|
213 N Lombard Rd, Addison, IL 60101-1906 | |
| (630) 530-3681 | |
| Not Available |
| Full Name | Laura K Weinbrenner |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 213 N Lombard Rd, Addison, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598273096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.009309 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura K Weinbrenner, CCC-SLP/L 213 N Lombard Rd, Addison, IL 60101-1906 Ph: (630) 530-3681 | Laura K Weinbrenner, CCC-SLP/L 213 N Lombard Rd, Addison, IL 60101-1906 Ph: (630) 530-3681 |
News Archive
Having a high level of urinary dichlorophenols is associated with the presence of food sensitization and allergies, say researchers.
New research from a team at the Marshall University Joan C. Edwards School of Medicine reveals the central role of fat cells in the systemic oxidant stress observed in renal failure-associated cardiomyopathy.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-release Tablets, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg.
Could a decades-old antidepressant be a secret weapon against covid? A few scientists think so, after two small studies showed that fluvoxamine, typically prescribed for obsessive-compulsive disorder, prevented serious illness in all participants who took the pills soon after developing symptoms.
› Verified 2 days ago
Miss Kyla Nikol Bunch, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2171 W Executive Dr, Addison, IL 60101 Phone: 630-766-0505 | |
Erin Kristine Dini, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 Fax: 630-766-6465 | |
Mrs. Amanda Guida, M.A. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 720 N Lincoln Ave, Addison, IL 60101 Phone: 630-458-3060 | |
Anita Marie Costabile, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1215 W Fullerton Ave, Addison, IL 60101 Phone: 630-372-2565 | |
Elin N Kuzmack, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 | |
Veronica Lynn Bieniek, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 N Forest Ct, Addison, IL 60101 Phone: 630-965-4208 | |
Sandra Lee Petersen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 W Stonemill Ave, Addison, IL 60101 Phone: 630-628-4165 |